Read some of our articles for the latest thinking in the Clinical Research and Digital Health industries.
The clinical trial industry is faced with both a deeply entrenched set of challenges and a fast-growing collection of technologies with the potential to address these problems. How sponsors, vendors, and other stakeholders manage this situation will go a long way to deciding the shape of clinical trials in the years to come.
Recent advances have proven successful in keeping participants engaged in clinical studies, but have neglected to consider two other important stakeholders – namely sponsors and CROs. What can they gain by implementing such technologies?
The last decade has seen the emergence of a new player in the completion of clinical outcome assessments (COAs): electronic data collection. This method of capturing information directly from patients is proving to be an ever-more valuable tool for sponsors, sites and patients themselves, facilitated by the global growth of mobile technology. It has created new, more efficient ways to access patients and provides an ideal platform for capturing assessment data, commonly known as patient-reported outcomes (PRO).
Electronic Clinical Outcomes Assessment (eCOA) providers are facing heightened demand for user-friendly, accessible solutions that facilitate hassle-free participation in clinical trials. This has sparked debate on how to deliver apps across the different operating platforms of iOS, Android and Windows in order to provide the best user experience. In particular – and for good reason – the use of native apps is becoming an increasingly popular choice.
Tim Davis explains how advances in mobile digital technology can now benefit not only patients but other key stakeholders involved in the clinical trial process: sites, investigators and study teams.